Patents by Inventor Seetharamaiah Setty S. Naremaddepalli

Seetharamaiah Setty S. Naremaddepalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS OF 3-SUBSTITUTED 1,2,4- OXADIAZOLE
    Publication number: 20230278970
    Abstract: The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.
    Type: Application
    Filed: May 15, 2023
    Publication date: September 7, 2023
    Inventors: Pottayil Govindan N. Sasikumar, Seetharamaiah Setty S. Naremaddepalli
  • Crystalline forms of 3-substituted 1,2,4-oxadiazole
    Patent number: 11680051
    Abstract: The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: June 20, 2023
    Assignee: Aurigene Discovery Technologies Limited
    Inventors: Pottayil Govindan N. Sasikumar, Seetharamaiah Setty S. Naremaddepalli
  • DUAL INHIBITORS OF TIM-3 AND PD-1 PATHWAYS
    Publication number: 20230062570
    Abstract: The present disclosure relates to 3-substituted 1,2,4-oxadiazole compounds and their derivatives, which are useful as T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) inhibitors or as dual inhibitors of TIM-3 and the programmed cell death 1 (PD-1) signaling pathway. The disclosure also relates to treatment of disorders by inhibiting an immunosuppressive signal induced by TIM-3, PD-1, PD-L1, and/or PD-L2.
    Type: Application
    Filed: October 7, 2022
    Publication date: March 2, 2023
    Inventors: Pottayil Govindan N. Sasikumar, Muralidhara Ramachandra, Seetharamaiah Setty S. Naremaddepalli, Nagaraj Gowda
  • Dual inhibitors of TIM-3 and PD-1 pathways
    Patent number: 11497734
    Abstract: The present disclosure relates to 3-substituted 1,2,4-oxadiazole compounds and their derivatives, which are useful as T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) inhibitors or as dual inhibitors of TIM-3 and the programmed cell death 1 (PD-1) signaling pathway. The disclosure also relates to treatment of disorders by inhibiting an immunosuppressive signal induced by TIM-3, PD-1, PD-L1, and/or PD-L2.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: November 15, 2022
    Assignee: Aurigene Discovery Technologies Limited
    Inventors: Pottayil Govindan N. Sasikumar, Muralidhara Ramachandra, Seetharamaiah Setty S. Naremaddepalli, Nagaraj Gowda
  • CRYSTALLINE FORMS OF 3-SUBSTITUTED 1,2,4- OXADIAZOLE
    Publication number: 20220048875
    Abstract: The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.
    Type: Application
    Filed: August 30, 2021
    Publication date: February 17, 2022
    Inventors: Pottayil Govindan N. Sasikumar, Seetharamaiah Setty S. Naremaddepalli
  • Crystalline forms of 3-substituted 1,2,4-oxadiazole
    Patent number: 11136300
    Abstract: The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: October 5, 2021
    Assignee: Aurigene Discovery Technologies Limited
    Inventors: Pottayil Govindan N. Sasikumar, Seetharamaiah Setty S. Naremaddepalli
  • CRYSTALLINE FORMS OF 3-SUBSTITUTED 1,2,4- OXADIAZOLE
    Publication number: 20200239422
    Abstract: The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.
    Type: Application
    Filed: October 10, 2018
    Publication date: July 30, 2020
    Inventors: Pottayil Govindan N. Sasikumar, Seetharamaiah Setty S. Naremaddepalli
  • DUAL INHIBITORS OF VISTA AND PD-1 PATHWAYS
    Publication number: 20200061030
    Abstract: The present disclosure relates to 3-substituted 1,2,4-oxadiazole compounds and their derivatives, which are useful as V-domain immunoglobulin suppressor of T-cell activation (VISTA) inhibitors or as dual inhibitors of VISTA and the programmed cell death 1 (PD-1) signaling pathway. The disclosure also relates to treatment of disorders by inhibiting an immunosuppressive signal induced by VISTA and its ligands, PD-1, PD-L1, and/or PD-L2.
    Type: Application
    Filed: October 18, 2017
    Publication date: February 27, 2020
    Inventors: Pottayil Govindan N. Sasikumar, Muralidhara Ramachandra, Seetharamaiah Setty S. Naremaddepalli